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A B S T R A C T
A 17-year-old female was referred for evaluation of fever of two-month duration with acute onset of
dyspnea since 1 week. Clinical examination revealed tachycardia, tachypnea, elevated jugular venous
pressure, bilateral basal crepitations with normal heart sounds, and no murmur. Chest X-ray showed
inﬁltrates in bilateral lung ﬁelds. Echocardiography revealed obliteration of biventricular apices along
with layered thrombus over the left ventricular endocardium. Doppler studies elicited restrictive
physiology with mild mitral and tricuspid regurgitation. Complete hemogram revealed hypereosino-
philia with eosinophilic count of 7.4  109/L. All secondary causes of elevated eosinophil count were
excluded. The patient was started on steroids and anticoagulation. Serial echocardiograms showed
clearing of the thrombus with marked symptomatic improvement. We highlight a case of idiopathic
hypereosinophilic syndrome with classic cardiac (Loefﬂer endocarditis) and pulmonary manifestations
and prompt recovery with steroids and anticoagulation.
<Learning objective: Idiopathic hypereosinophilic syndrome is a rare entity leading to multi-organ
involvement. Cardiac involvement is one of the most common causes of morbidity and mortality. On the
basis of this case report, we discuss Loefﬂer endocarditis in idiopathic hypereosinophilic syndrome;
demonstrate classic echocardiographic ﬁndings in the intermediate stage, and remarkable symptomatic
and echocardiographic recovery after appropriate treatment.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Hypereosinophilic syndrome (HES) was ﬁrst described by Hardy
and Anderson in 1968, characterized by overproduction of
eosinophils and varying degree of organ involvement [1]. Mortality
in untreated patients can be as high as 75% at three years [2]. Cardiac
involvement (Loefﬂer endocarditis) is the most common cause of
increased morbidity and mortality [3]. Cardiac imaging in the form
of echocardiogram and magnetic resonance imaging (MRI) are
cornerstones of diagnosis in cases with cardiac involvement. Early
recognition of the cardiac disease is of paramount importance to
prevent morbidity and mortality associated with the later stages.
Case report
A 17-year-old female was referred to our department for
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reaction, arthritis, or allergic reactions. Clinical examination
revealed tachycardia, tachypnea, raised jugular venous pressure,
with normal heart sounds, and no murmur. Chest X-ray revealed
bilateral lung inﬁltrates (Fig. 1a) and electrocardiogram showed
non-speciﬁc ST-T changes. Two-dimensional transthoracic echo-
cardiogram showed obliteration of biventricular apices with a
layered thrombus extending over the left ventricle endocardium
(Fig. 2a,c; Videos 1a and 2a). Color Doppler echocardiography
showed mild mitral and tricuspid regurgitation. Pulse wave
Doppler echocardiography and tissue Doppler echocardiography
elicited restrictive physiology (Fig. 2e,g). Laboratory investigations
revealed increased eosinophil counts (7.4  109/L) with no
abnormal cells on peripheral smear. All secondary causes of
eosinophilia were excluded. The patient’s laboratory investigations
revealed negative anti-nuclear antibody (ANA), negative rheuma-
toid antibody factor, negative cytoplasmic-anti-neutrophil cyto-
plasmic antibody (ANCA), perinuclear-ANCA, normal IgE levels,
normal vitamin B12 levels, normal urine examination with no
proteinuria, and normal stool examination with no evidence of
parasitic infection (Table 1). Ultrasonography of the abdomen
revealed mild splenomegaly with no other abnormality. Bone reserved.
Fig. 1. (a) X-ray chest showing pulmonary inﬁltrates in bilateral lung ﬁelds. (b) Complete resolution of inﬁltrates after four weeks of therapy.
Fig. 2.
(a) Two-dimensional transthoracic echocardiogram, apical four-chamber view, depicting obliteration of apices of both ventricles along with thrombus on the left
ventricular endocardium. (b) Signiﬁcant resolution of thrombus after one month of treatment. (c) Parasternal short-axis view, showing near total obliteration of
left ventricular cavity with thrombus. (d) Parasternal short-axis view, showing decrease in the thrombus after 4 weeks of treatment. (e) Pulse wave Doppler
echocardiography showing restrictive physiology. (f) Pulse wave Doppler echocardiography, post treatment, showing normal transmitral ﬂow velocity pattern.
(g) Tissue Doppler echocardiography showing low mitral annular velocity (E0) and high E/E0 ratio suggestive of restrictive physiology. (h) Tissue Doppler
echocardiography, after 4 weeks of treatment, showing normal mitral annular velocity (E0) reﬂective normal ﬁlling pattern. LA, left atrium; LV, left ventricle; RA,
right atrium; RV, right ventricle.
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Table 1 Laboratory work up of the patient.
Complete haemogram Liver function tests Renal function tests Immunological tests
Haemoglobin: 10.0 (g/dl) Serum bilirubin: (1.1mg/dl) Blood urea: 18 (mg/dl) ANA(ELISA): Negative
TLC: 24,800/mm3 AST: 35 (IU/L) Serum creatinine: 1.0 (mg/dl) RA Factor: Negative
Neutrophils: 42% ALT: 38 (IU/L) p-ANCA: Negative
Lymphocytes: 24% Alkaline phosphatase: 188 (IU/L) c-ANCA: Negative
Monocytes: 4% Serum proteins: 6.2 (g/dl) IgE: 0.10 IU/ml
Eosinophils: 30% Serum Albumin: 3.4 (g/dl)
Basophils: 0–1% PT INR: 1.1
Absolute eosinophil count: 7480/mm3
Platelets: 1.2  105/mm3
ALT: Alanine transaminase, ANA: Anti-nuclear antibody, c-ANCA: Cytoplasmic-Anti-neutrophil cytoplasmic antibody, p-ANCA: Perinuclear-Anti-neutrophil cytoplasmic
antibody, AST: Aspartate transaminase, Ig E: Immunoglobulin E, PT INR: Prothrombin time- International normalized ratio, RA factor: Rheumatoid antibody, TLC: Total
leucocyte count.
Table 2 Hematological response to therapy.
White blood cells Admission 4 weeks of treatment
Total leukocyte count (cells/mm3) 24,800 12,500
Neutrophils (%) 42 76
Lymphocytes (%) 24 22
Monocytes (%) 4 1
Eosinophils (%) 30 0.5
Absolute eosinophil count (cells/mm3) 7480 740
Basophils (%) 0.8 0.5
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26% eosinophils, normal percentage of blasts, and no dysplastic
cells. Karyotyping was normal. A diagnosis of idiopathic HES with
Loefﬂer endocarditis was made and the patient was started on
diuretics, angiotensin-converting enzyme (ACE) inhibitors, ster-
oids (1 mg/kg for 4 weeks followed by gradual tapering), and oral
anticoagulation. After 4 weeks of treatment, the patient was
asymptomatic and eosinophil count was normal (0.75  109/L)
(Table 2). Inﬁltrates on chest X-ray resolved completely (Fig. 1b).
Serial echocardiograms revealed marked reduction in the throm-
bus and the left ventricular obliteration resolved signiﬁcantly
(Fig. 2b,d; Videos 1b, 2b). The restrictive pattern on pulse wave
Doppler echocardiography and tissue Doppler echocardiography
also became normal (Fig. 2f,h). Cardiac MRI (CMR), on follow up,
revealed absence of signiﬁcant layered thrombus and normal left
ventricular function with mild patchy late gadolinium enhance-
ment of the left ventricular wall along with a small apical left
ventricular aneurysm (Fig. 3a,b; Video 3). The patient was advised
to continue diuretics, ACE inhibitors, steroids, and oral antic-
oagulation.Fig. 3.
(a) After four weeks of treatment, cardiac magnetic resonance imaging (MRI) s
Cardiac MRI on follow-up, showing no signiﬁcant thrombus in the ventricleDiscussion
In 1975, Chusid was the ﬁrst to establish three diagnostic criteria
for HES: (a) persistent eosinophilia of 1500 eosinophils/mm3 or
more for longer than six months; with (b) lack of evidence for
allergic, parasitic, or other known causes of eosinophilia; and (c)
symptoms and signs of organ involvement [4]. Over the past
30 years, the heterogeneous group of disorders constituting HES are
decreasing, as separate disease entities are recognized. If a patient
fulﬁlls Chusid’s criteria and no cause is found for the eosinophilia
after thorough investigation, the World Health Organization
classiﬁes this patient as having idiopathic HES [5]. Cardiac involve-
ment is found in 50% of the cases of HES [3]. Loefﬂer endocarditis is
used to describe the involvement of the heart in HES [6]. Cardiac
disease follows three stages. The ﬁrst is an acute necrotic stage due to
inﬁltration of eosinophils in the myocardium. The contents of the
eosinophilic granules (eosinophilic major basic protein, eosinophilic
cationic protein, and eosinophil protein-X) are present within the
endocardium and myocardium and are held responsible for
initiating the damage [7]. This stage can be asymptomatic in many
cases. This is followed by an intermediate phase characterized by
mural thrombi and thrombus formation along the damaged
endocardium (thrombotic stage) [7]. The left ventricle is more
affected and thrombus tends to form at apex where stasis is
prominent [8]. The third stage is the ﬁbrotic stage in which the
granulation tissue is changed into hyaline ﬁbrosis, sometimes with a
small inﬂammatory zone in deeper layer [7].
Echocardiogram shows endomyocardial thickening in more
than 60% of patients [9]. Apical obliteration with thrombus and
involvement of posterior mitral leaﬂet causing mitral regurgitation
are classic ﬁndings. Doppler echocardiography will usually show
restrictive physiology. Pericardial effusion can also be found.howing mild patchy late gadolinium enhancement of left ventricular (LV) wall. (b)
s with a small apical aneurysm.
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and systemic embolization. CMR is useful in HES. Hyperintense
myocardial area on T2 weighted images is suggestive of edema or
necrosis and is usually found at apex in such patients. Delayed
gadolinium enhancement of non-ischemic type is characteristic of
ﬁbrosis. CMR has high sensitivity and speciﬁcity for detecting
apical thrombi. Overlying thrombus is identiﬁable as a low signal
mass on the delayed enhancement images, which does not deform
on tagged images. Regional areas of hypokinesia or akinesia and
estimation of cardiac function can also be determined by CMR.
Treatment at early stage can prevent progression to endocardial
ﬁbrotic stage in which morbidity and mortality remain highest.
Steroids are the cornerstone of treatment. Hydroxyurea and
interferon a can be used in steroid-resistant patients. Novel
therapies including alemtuzumab, a human monoclonal antibody
directed against CD52 on eosinophils, have been reviewed
[10]. Patients with fusion protein with tyrosine kinase activity
encoded by the FIP1L1-PDGRFA-fusion gene are highly responsive
to imatinib. The most important part in treatment is to start the
therapy in early stages as once the ﬁbrotic stage sets in, it is
irreversible with poor results on medical therapy.
Our patient presented in intermediate stage, which was
promptly recognized and appropriate treatment was initiated.
We highlight a classic case of idiopathic HES with typical cardiac
(Loefﬂer endocarditis) and pulmonary manifestations.
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